Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins

Mendivil, Carlos O., Zheng, Chunyu, Furtado, Jeremy, Lel, Julian, Sacks, Frank M.·2010·Arteriosclerosis, Thrombosis, and Vascular Biology
DOI 10.1161/atvbaha.109.197830

Cited by (145)

Items 101–145 of 145

  1. Apolipoprotein C-III
    Michael J. Miller · 2017 · Arteriosclerosis Thrombosis and Vascular Biology
  2. Metabolism of apolipoprotein A-II containing triglyceride rich ApoB lipoproteins in humans
    Nirav K. Desai, Esther M. M. Ooi, Paul D. Mitchell, Jeremy D. Furtado, Frank M. Sacks · 2015 · Atherosclerosis
  3. Impacto del ejercicio sobre el metabolismo de los lípidos y la dislipidemia
    Eitan A. Scher-Nemirovsky, Daniel Ruiz Manco, Carlos Olimpo Mendivil · 2019 · Revista de Nutrición Clínica y Metabolismo
  4. Plasma proteoforms of apolipoproteins C-I and C-II are associated with plasma lipids in the Multi-Ethnic Study of Atherosclerosis
    Juraj Koška, Jeremy D. Furtado, Yueming Hu, Shripad A. Sinari, Matthew Jay Budoff, Dean D. Billheimer, Dobrin Nedelkov, Robyn L. McClelland, Peter D. Reaven · 2022 · Journal of Lipid Research
  5. Cellular, Molecular and Proteomic Characteristics of Early Hepatocellular Carcinoma
    Athanasios Armakolas, Vasiliki Dimopoulou, Adrianos Nezos, George M. Stamatakis, Martina K. Samiotaki, George Panayotou, Maria Tampaki, Martha Stathaki, Spyridon P. Dourakis, John S. Koskinas · 2022 · Current Issues in Molecular Biology
  6. Analysis of low‐density lipoprotein‐associated proteins using the method of digitized native protein mapping
    Ya Jin, Jin Chen, Ahui Wang, Jun Zhang, Shumin Chen, Takashi Manabe, Wen Tan · 2016 · Electrophoresis
  7. Increasing the complexity of lipoprotein characterization for cardiovascular risk in type 2 diabetes
    Montse Guardiola, Pere Rehues, Núria Amigó, Francisco Arrieta, Manuel Botana, José Antonio Gimeno-Orna, Josefa Girona, José Ignacio Martínez‐Montoro, Emilio Ortega, Antonio Pérez et al. · 2024 · European Journal of Clinical Investigation
  8. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
    Charlotte Green, Camilla Pramfalk, Catriona A. Charlton, Pippa J. Gunn, Thomas Cornfield, Michael Pavalides, Fredrik Karpe, Leanne Hodson · 2019 · Endocrine Abstracts
  9. The Efficacy and Safety of Plozasiran on Lipid Profile in Dyslipidemic Disorders: A Systematic Review and Meta-Analysis
    Sydhom, Pishoy, Al-Quraishi, Bakr, Gohar, Aya, El-Shawaf, Mohamad, Shehata, Nahla, Ataya, Miral, Sydhom, Mark, Awwad, Nouran, Motawade, Haidy, Naji, Nourhan et al. · 2026 · Cardiovascular Drugs and Therapy
  10. Apolipoproteins in circulation: At the interface of thrombosis and stroke initiation
    Tamara Etuzé, Denis Vivien, Fatéméh Dubois · 2025 · Progress in Lipid Research
  11. A Combined Fertility and Developmental Toxicity Study with an Antisense Oligonucleotide Targeting Murine Apolipoprotein C-III mRNA in Mice
    Ji‐Seong Jeong, Archit Rastogi, Tae‐Won Kim, Scott P. Henry, Christine M. Hoffmaster, Sang Yun Kim, Woojin Kim, Sun-Young Lee, Jeong‐Dong Park, In-Su Wi et al. · 2024 · Nucleic Acid Therapeutics
  12. ApoC-III proteoforms are associated with better lipid, inflammatory, and glucose profiles independent of total apoC-III
    Pere Rehues, Josefa Girona, Montse Guardiola, Enrique Ozcariz, Núria Amigó, Roser Rosales, Yaiza Esteban, Helena Banús, Gemma Gavaldà Alsina, Ana María González-Lleó et al. · 2024 · Cardiovascular Diabetology
  13. Enrichment of Triglyceride-Rich Lipoproteins with Apolipoprotein C-I Is Positively Associated with Their Delayed Plasma Clearance Independently of Other Transferable Apolipoproteins in Postmenopausal Overweight and Obese Women
    Hanny Wassef, Simon Bissonnette, Robert Dufour, Jean Davignon, May Faraj · 2017 · Journal of Nutrition
  14. Decreased Efficiency of Very-Low-Density Lipoprotein Lipolysis Is Linked to Both Hypertriglyceridemia and Hypercholesterolemia, but It Can Be Counteracted by High-Density Lipoprotein
    Ewa Wieczorek, Agnieszka Ćwiklińska, Agnieszka Kuchta, Barbara Kortas‐Stempak, Anna Gliwińska, Maciej Jankowski · 2021 · Nutrients
  15. Posicionamento Brasileiro sobre Síndrome da Quilomicronemia Familiar – 2023
    Maria Cristina de Oliveira Izar, Raul Dias Santos, Marcelo Heitor Vieira Assad, Antônio Carlos Palandri Chagas, Alceu de Oliveira Toledo, Ana Cláudia Cavalcante Nogueira, Ana Cristina Carneiro Fernandes Souto, Ana Maria Lottenberg, Ana Paula Marte Chacra, Carlos Eduardo dos Santos Ferreira et al. · 2023 · Arquivos Brasileiros de Cardiologia
  16. Why Are Internal Mammary (Thoracic) Arteries Less Prone to Developing Atherosclerosis Compared to Coronary Arteries? Do Gut Microbiota Play a Role? A Narrative Review
    Leon M. T. Dicks · 2025 · International Journal of Molecular Sciences
  17. Assessment of apolipoproteinsA1, E, and Insulin Resistance in Iraqi male patients with acute myocardial infarction
    Hind Sh. Ahmed · 2020 · Iraqi Journal of Community Medicine
  18. MENINGKATKAN KOLESTEROL HDL Paradigma baru dalam pencegahan penyakit kardiovaskular
    Starry Homenta Rampengan · 2015 · Jurnal Biomedik JBM
  19. Breaking the chains of lipoprotein lipase deficiency: A pediatric perspective on the efficacy and safety of Volanesorsen
    Bibiche den Hollander, Marion M. M. G. Brands, Ilse J.M. Nijhuis, Lous J.A.E. Doude van Troostwijk, Peter van Essen, G.H. Hofsteenge, Bart G.P. Koot, Annelieke R. Müller, Laura A. Tseng, Erik S.G. Stroes et al. · 2024 · Molecular Genetics and Metabolism
  20. Relationship of apolipoprotein C-III proteoform composition with ankle-brachial index and peripheral artery disease in the Multi-Ethnic Study of Atherosclerosis (MESA)
    Juraj Koška, Spencer L. Hansen, Yueming Hu, Majken Jensen, Dean D. Billheimer, Dobrin Nedelkov, Matthew Jay Budoff, Matthew Allison, Robyn L. McClelland, Peter D. Reaven · 2024 · Atherosclerosis
  21. Food Intake Suppresses ApoB Secretion and Fractional Catabolic Rates in Humans
    Chunyu Zheng, Allison B. Andraski, Christina Khoo, Jeremy D. Furtado, Frank M. Sacks · 2024 · Arteriosclerosis Thrombosis and Vascular Biology
  22. New Biotechnological Treatments for Lipid Disorders
    Natalia Valencia‐Enciso, Carlos Olimpo Mendivil · 2018 · Revista de investigaci�n Cl�nica
  23. Dietary Pattern Low in Fruits Explains Variations in Inflammation and in Biomarkers of Cardiovascular Disease in Latinos Diagnosed with Type-2 Diabetes
    Mariana C. Calle · 2013 · Journal of Advances in Medicine and Medical Research
  24. Triglyceride-independent associations between circulating levels of apolipoprotein C-III and biomarkers of inflammation
    Dídac Llop, Pere Rehues, Sílvia Paredes, Montse Guardiola, Josefa Girona, Roser Rosales, Yaiza Esteban, L. Masana, Daiana Ibarretxe, Joan-Carles Vallvé et al. · 2025 · Cardiovascular Diabetology
  25. Dysapolipoproteinaemia Influences the Relationship Between Very Low-Density Lipoprotein Cholesterol and Intra-Pancreatic Fat Deposition in Humans
    Yutong Liu, Loren Skudder‐Hill, Juyeon Ko, Xiatiguli Shamaitijiang, Ivana Roosevelt Sequeira, Maxim S. Petrov · 2025 · Nutrients
  26. Hepatitis C virus and lipid profiles: more questions than answers?
    Ching‐Sheng Hsu, Jia‐Horng Kao · 2011 · Hepatology International
  27. Investigations of apoC-III metabolism using stable isotopes: what information can you acquire and how can you interpret your results?
    Associate Editor Henry N. Ginsberg, Rajasekhar Ramakrishnan · 2011 · Journal of Lipid Research
  28. Investigating Cholesterol Metabolism and Its Intersection with Ageing
    Mark T. Mc Auley · 2019 · Springer eBooks
  29. The Role of Omega-3 Fatty Acids in Dyslipidemias
    Eric J. Brandt, Michael H. Davidson · 2015 · Springer eBooks
  30. APOC3 and ABCA1 variants in unusual combined hypolipidaemia showing premature peripheral vascular disease
    Zuzana Pös, Milad Khedr, Ján Radvánszky, Adela Penesová, Rastislav Hekel, Tomáš Szemes, Lakshminarayan R Ranganath, Andrea Zaťková · 2023 · Bratislavské lekárske listy/Bratislava medical journal
  31. Production and Metabolism of Triglyceride-Rich Lipoproteins: Impact of Diabetes
    Angela Pirillo, Giuseppe Danilo Norata, Alberico Luigi Catapano · 2023 · Contemporary diabetes
  32. Lipoprotein distribution of Apo CIII glycoforms in healthy men is linked with low TG and increased insulin sensitivity
    M. Mar Rodríguez, Pere Rehues, Víctor Iranzo, Jorge Díaz Mora, Clara Balsells, Montse Guardiola, Josep Ribalta · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  33. In vitro characterization of telmisartan-derived compounds for selective peroxisome-proliferator activated receptor gamma (PPARγ) modulation
    Lena Herbst · 2012 · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver
  34. Studies of Atherogenic Lipoproteins Using Mass Spectrometry-Based Lipidomics
    Marcus Ståhlman · 2010 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  35. Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes
    Thomas D. Dayspring · 2013 · Contemporary diabetes
  36. Modificações oxidativas de lipoproteínas de baixa densidade e seus anticorpos
    Paolla Fernanda Cezar Ferreira · 2011
  37. Mirror image serum lipid carrier protein profiles in pup and lactating mother Atlantic grey seals reflect contrasting resource mobilisation challenges
    Suzanne McGill, Richard Burchmore, Patrick P. Pomeroy, Malcolm W. Kennedy · 2022 · Frontiers in Marine Science
  38. Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes
    Thomas D. Dayspring, Peter Paul Toth · 2023 · Contemporary diabetes
  39. SNHG15 is involved in the progression of atherosclerosis through targeted regulation of miR-370-3p and bioinformatics analysis
    Wan Pan, Yan Zhou, Fan Zhang, Yingying Zhang, Wei Li, Chengpeng Li, Liqun He · 2024 · Archives of Medical Science
  40. Characterization of metabolically healthy and unhealthy obesity through circulating proteins and metabolites
    Giulia Pontali, Christian X. Weichenberger, Johannes Rainer, Essi Marjatta Hantikainen, Marilyn De Graeve, Fulvio Mattivi, Michael Kob, Markus Ralser, Peter Paul Pramstaller, Francisco S. Domingues · 2025 · medRxiv
  41. Identifying the molecular association between diabetic nephropathy and hepatocellular carcinoma: an in-silico network biology approach
    Tammanna Ravee Sahrawat, Arnesh Saxena · 2025 · Journal of Medicine and Life Science
  42. Fenofibrate vs. Omega-3 in Pediatric Hypertriglyceridemia: A Randomized Controlled Trial
    Setila Dalili, Shahin Koohmanaee, Afagh Hassanzadeh Rad, Parnian Nemati, Habibeh Mashayekhi‐Sardoo, Reza Bayat, Maryam Shahrokhi · 2026 · Journal of Pediatric Health Care
  43. Efficacy and safety of antisense oligonucleotide therapies targeting APoC-III in patients with severe hypertriglyceridemia: a meta-analysis of randomized controlled trials
    Abdullah Masood, Azhar Ul Hassan Qureshi, Zahra Khalid, Hiba Shahid, Abdul Raheem Khurshid Malik, Subooh Javed, Meeral Mandahar, Amanullah Amanullah, Yumna Siddiqui, Talha Anwar et al. · 2026 · Monaldi Archives for Chest Disease
  44. Characterization of metabolically healthy and unhealthy obesity by circulating omics
    Giulia Pontali, Christian X. Weichenberger, Johannes Rainer, Essi Marjatta Hantikainen, Marilyn De Graeve, Fulvio Mattivi, Michael Kob, Markus Ralser, Peter Paul Pramstaller, Francisco S. Domingues · 2026 · Nutrition Metabolism and Cardiovascular Diseases
  45. Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy
    Tejal Aslesh, Toshifumi Yokota · 2026 · Methods in molecular biology